Intravesical Instillation of Chemotherapy Before Radical Surgery for Upper Urinary Tract Urothelial Carcinoma: The REBACARE Trial
Preoperative IIC with mitomycin C was feasible and well tolerated and significantly reduced IVR risk for patients without d-URS. These findings suggest that preoperative IIC is a viable strategy for this subset of UTUC patients and that d-URS should be performed judiciously.
Authors
- Katja K.H. Aben (ORCID: https://orcid.org/0000-0002-0214-2147)
- Jorg R. Oddens (ORCID: https://orcid.org/0000-0002-6079-5613)
- Peter de Vries (ORCID: https://orcid.org/0000-0001-9710-8752)
- Erik B. Cornel
- Sebastiaan Remmers (ORCID: https://orcid.org/0000-0001-9530-6448)
- L.A.J. Roelofs
- Bob Merks
- Benjamin Pradère (ORCID: https://orcid.org/0000-0002-7768-8558)
- Richard P. Meijer (ORCID: https://orcid.org/0000-0003-2510-7982)
- Diederik M. Somford (ORCID: https://orcid.org/0000-0002-5277-6586)
- Antoine G. van der Heijden (ORCID: https://orcid.org/0000-0002-8839-8601)
- Bin K. Kroon (ORCID: https://orcid.org/0000-0002-5183-0720)
- Peter J. Zwaan
- Harm van Melick
- Thomas van Doeveren (ORCID: https://orcid.org/0000-0002-9697-4293)
- Anna M. Leliveld (ORCID: https://orcid.org/0000-0002-7028-0824)
- Marit J. Yska
- Kees Hendricksen
- Joost L. Boormans
- Egbert R. Boevé
- Pim J. van Leeuwen (ORCID: https://orcid.org/0000-0002-9598-5345)
- Rens A. L. Jacobs
- Bart P. Wijsman
- Evelyne C. C. Cauberg
- Willemijn A.K.M. Windt
Institutions
- University Medical Center Groningen (NL)
- Radboud University Nijmegen (NL)
- Gelre Hospitals (NL)
- Radboud University Medical Center (NL)
- The Netherlands Cancer Institute (NL)
- University Medical Center Utrecht (NL)
- Sint Franciscus Gasthuis (NL)
- Medisch Centrum Haaglanden (NL)
- St. Antonius Ziekenhuis (NL)
- Amsterdam Neuroscience (NL)
- Maasstad Ziekenhuis (NL)
- Treant Zorggroep (NL)
- Martini Ziekenhuis (NL)
- Groupe Hospitalier Diaconesses Croix Saint-Simon (FR)
- Canisius-Wilhelmina Ziekenhuis (NL)
- Zuyderland Medisch Centrum (NL)
- Netherlands Comprehensive Cancer Organisation (NL)
- Isala (NL)
- Elisabeth-TweeSteden Ziekenhuis (NL)
- Ziekenhuis Groep Twente (NL)
- Erasmus MC Cancer Institute (NL)
- Franciscus Vlietland (NL)
- Rijnstate Hospital (NL)
- Amsterdam University of Applied Sciences (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- European Urology
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1016/j.eururo.2024.12.006
- Citations
- 16
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 32.10
Funders
- KWF Kankerbestrijding